Novel benzofuran enantiomers reduced liver damage and cytokines in HepG2 cells, suggesting therapeutic potential.
This study isolated two novel benzofuran enantiomer pairs with fused cyclopropane motifs from R. graveolens Their structures were confirmed via a new catalytic EDA complex synthesis. Racemic mixtures reduced LPS-induced liver/cellular damage and cytokines in HepG2 cells, while all enantiomers inhibited MAO-B.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: